What is the most common cause of central retinal (ophthalmic) artery thrombosis?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: March 6, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

From the Guidelines

The most common cause of central retinal (ophthalmic) artery thrombosis is atherosclerosis, particularly carotid stenosis, which is discovered in up to 70% of patients with symptomatic central retinal artery occlusion (CRAO) 1.

Key Points

  • Atherosclerosis is the primary cause of central retinal artery thrombosis, leading to turbulent blood flow, endothelial damage, and subsequent thrombus formation.
  • Risk factors that significantly contribute to CRAO include hypertension, diabetes mellitus, hyperlipidemia, advanced age, and hypercoagulable states.
  • Patients with CRAO typically present with sudden, painless vision loss in one eye, and may have a relative afferent pupillary defect and characteristic funduscopic findings.
  • Management focuses on treating underlying risk factors, controlling intraocular pressure, and addressing complications such as macular edema with intravitreal anti-VEGF injections or steroids.
  • Early diagnosis and treatment are essential to prevent permanent vision loss, and patients with acute retinal artery occlusion (RAO) should be referred immediately to an emergency department or stroke center facility for neurological evaluation due to the increased risk of central nervous system stroke 1.

Clinical Considerations

  • The use of hyperbaric oxygen therapy has demonstrated efficacy in several small randomized trials, but its role in the management of CRAO is still limited 1.
  • Panretinal photocoagulation (PRP) with or without anti-vascular endothelial growth factor (anti-VEGF) therapy is recommended for patients who develop iris or retinal neovascularization 1.
  • Antiplatelet and statin therapies will apply to the vast majority of affected patients, while carotid surgery will apply to less than 30% of patients 1.

From the Research

Causes of Central Retinal Artery Thrombosis

There are no research papers provided that directly answer the question about the most common cause of central retinal (ophthalmic) artery thrombosis. However, some studies discuss the causes of central retinal vein occlusion, which may be related.

Related Causes of Central Retinal Vein Occlusion

  • Predisposing factors such as hypertension, diabetes, atherosclerosis, and hypercoagulable states have been described as potential causes of central retinal vein occlusion 2, 3.
  • Local ophthalmic illnesses such as open angle glaucoma, ocular trauma, and orbital infections have also been suggested as causative factors 2.
  • Disordered blood rheology, changes in the local hemostatic potential, and impaired blood stream in the corresponding retinal vein branches have been identified as major factors contributing to the pathogenesis of central retinal vein thrombosis 4.

Key Findings

  • The majority of central retinal vein occlusions occur in patients over 65 years old 2, 3.
  • Macular edema and neovascularization are common complications of central retinal vein occlusion 3, 5, 6.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Retinal vein thrombosis: pathogenesis and management.

Journal of thrombosis and haemostasis : JTH, 2010

Research

Central Retinal Vein Occlusion: A Review of Current Evidence-based Treatment Options.

Middle East African journal of ophthalmology, 2016

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.